Literature DB >> 27773565

The cytotoxic activity of miltefosine against Leishmania and macrophages is associated with dynamic changes in plasma membrane proteins.

Kelly Souza Fernandes1, Paulo Eduardo Narcizo de Souza2, Miriam Leandro Dorta3, Antonio Alonso4.   

Abstract

In this study, we combined electron paramagnetic resonance (EPR) spectroscopy with an analysis of biophysical cellular parameters to study the mechanisms underlying the in vitro anti-leishmanial activity of miltefosine (MT). A thiol-specific spin label attached to membrane-bound proteins of Leishmania amazonensis and peritoneal macrophages indicated that MT may bind to plasma membrane proteins in large quantities via a detergent-like action and cause structural changes associated with a marked increase in dynamics and exposure to an aqueous environment. EPR spectra of a spin-labeled stearic acid indicated strong interactions between the probe and membrane proteins and a marked increase in the membrane fluidity of MT-treated cells. The cytotoxicity of MT was found to depend on the cell concentration used in the assay. This dependence was described by an equation involving the 50% inhibitory concentrations of MT in the aqueous medium (cw50) and the cell membrane (cm50) and the membrane-aqueous medium partition coefficient of MT (K). With a cw50 of 8.7μM, macrophages were less sensitive to MT than amastigotes and promastigotes of Leishmania, which had cw50 values of 2.4-3.1μM. The estimated cm50 of MT for Leishmania was 1.8M, which appears sufficient to cause ruptures or formation of pores in the plasma membrane. Additionally, we demonstrated that the changes in the plasma membrane detected by EPR spectroscopy occurred at cytotoxic concentrations of MT, as assessed through in vitro assays. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Leishmania; Macrophages; Membrane fluidity; Miltefosine; Protein dynamics

Mesh:

Substances:

Year:  2016        PMID: 27773565     DOI: 10.1016/j.bbamem.2016.10.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  6 in total

1.  In Vitro Activities of Miltefosine and Antibacterial Agents from the Macrolide, Oxazolidinone, and Pleuromutilin Classes against Pythium insidiosum and Pythium aphanidermatum.

Authors:  Erico S Loreto; Juliana S M Tondolo; Daniele C Oliveira; Janio M Santurio; Sydney H Alves
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  In vitro efficacy of polymer coated miltefosine drug against leishmania tropica.

Authors:  Mehvish Khokhar; Muhammad Adnan Shereen; Momin Khan; Rahat Ullah Khan; Aamir Sohail; Imdad Ullah Khan; Inam Ullah Khan; Saadullah Khattak
Journal:  J Parasit Dis       Date:  2021-09-23

3.  In silico screening, molecular dynamic simulations, and in vitro activity of selected natural compounds as an inhibitor of Leishmania donovani 3-mercaptopyruvate sulfurtransferase.

Authors:  Vishnu Kant; Pawan Kumar; Ravi Ranjan; Prakash Kumar; Debabrata Mandal; Saravanan Vijayakumar
Journal:  Parasitol Res       Date:  2022-05-10       Impact factor: 2.383

4.  Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni.

Authors:  Maha M Eissa; Mervat Z El-Azzouni; Labiba K El-Khordagui; Amany Abdel Bary; Riham M El-Moslemany; Sara A Abdel Salam
Journal:  Parasit Vectors       Date:  2020-09-15       Impact factor: 3.876

5.  Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis.

Authors:  Ma Florencia Peralta; Nadina A Usseglio; Ma Estefanía Bracamonte; Ma Laura Guzmán; Ma Eugenia Olivera; J Diego Marco; Paola A Barroso; Dolores C Carrer
Journal:  Drug Deliv Transl Res       Date:  2021-01-27       Impact factor: 4.617

6.  Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages.

Authors:  Andrew A Voak; Joseph F Standing; Nuno Sepúlveda; Andy Harris; Simon L Croft; Karin Seifert
Journal:  J Antimicrob Chemother       Date:  2018-05-01       Impact factor: 5.790

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.